Crystal structure of middle east respiratory syndrome coronavirus (mers-cov) 3cl protease inactive mutant c148a Deposition Author(s): Schiffer, C.A. , Shaqra, A.M. , Zvornicanin, S.N.
Date: 2022-08-24 Method: X-RAY DIFFRACTION Resolution: 2.5 Å Organism(s): Middle East Respiratory Syndrome-Related Coronavirus Sequences Data: 8E7T_A , 8E7T_B , 8E7T_C , 8E7T_D
Crystal structure of sars-cov-2 mpro mutant e166a with pfizer intravenous inhibitor pf-00835231 Deposition Author(s): Schiffer, C.A. , Shaqra, A.M. , Zvornicanin, S.N.
Date: 2024-12-03 Method: X-RAY DIFFRACTION Resolution: 1.88 Å Organism(s): Severe Acute Respiratory Syndrome Coronavirus 2 Sequences Data: 9EL4_A , 9EL4_B
Crystal structure of sars-cov-2 mpro mutant e166v with pfizer intravenous inhibitor pf-00835231 Deposition Author(s): Schiffer, C.A. , Shaqra, A.M. , Zvornicanin, S.N.
Date: 2024-12-05 Method: X-RAY DIFFRACTION Resolution: 1.62 Å Organism(s): Severe Acute Respiratory Syndrome Coronavirus 2 Sequences Data: 9ELV_A , 9ELV_B
Crystal structure of sars-cov-2 mpro mutant l50f e166v with pfizer intravenous inhibitor pf-00835231 Deposition Author(s): Schiffer, C.A. , Shaqra, A.M. , Zvornicanin, S.N.
Date: 2024-12-06 Method: X-RAY DIFFRACTION Resolution: 1.84 Å Organism(s): Severe Acute Respiratory Syndrome Coronavirus 2 Sequences Data: 9MEI_A , 9MEI_B
Crystal structure of sars-cov-2 mpro s10a in complex with pfizer intravenous inhibitor pf-00835231 Deposition Author(s): Schiffer, C.A. , Shaqra, A.M. , Zvornicanin, S.N.
Date: 2025-04-12 Method: X-RAY DIFFRACTION Resolution: 1.9 Å Organism(s): Severe Acute Respiratory Syndrome Coronavirus 2 Sequences Data: 9O6D_A , 9O6D_B
Crystal structure of sars-cov-2 mpro s10c in complex with pfizer intravenous inhibitor pf-00835231 Deposition Author(s): Schiffer, C.A. , Shaqra, A.M. , Zvornicanin, S.N.
Date: 2025-04-13 Method: X-RAY DIFFRACTION Resolution: 1.99 Å Organism(s): Severe Acute Respiratory Syndrome Coronavirus 2 Sequences Data: 9O6E_A , 9O6E_B
Crystal structure of sars-cov-2 mpro s113a in complex with pfizer intravenous inhibitor pf-00835231 Deposition Author(s): Schiffer, C.A. , Shaqra, A.M. , Zvornicanin, S.N.
Date: 2025-04-13 Method: X-RAY DIFFRACTION Resolution: 1.97 Å Organism(s): Severe Acute Respiratory Syndrome Coronavirus 2 Sequences Data: 9O6F_A , 9O6F_B
Crystal structure of sars-cov-2 mpro s113c in complex with pfizer intravenous inhibitor pf-00835231 Deposition Author(s): Schiffer, C.A. , Shaqra, A.M. , Zvornicanin, S.N.
Date: 2025-04-14 Method: X-RAY DIFFRACTION Resolution: 2.28 Å Organism(s): Severe Acute Respiratory Syndrome Coronavirus 2 Sequences Data: 9O6P_A , 9O6P_B
Crystal structure of sars-cov-2 mpro l115a in complex with pfizer intravenous inhibitor pf-00835231 Deposition Author(s): Schiffer, C.A. , Shaqra, A.M. , Zvornicanin, S.N.
Date: 2025-04-14 Method: X-RAY DIFFRACTION Resolution: 2.21 Å Organism(s): Severe Acute Respiratory Syndrome Coronavirus 2 Sequences Data: 9O6Q_A , 9O6Q_B
Crystal structure of sars-cov-2 mpro l115m in complex with pfizer intravenous inhibitor pf-00835231 Deposition Author(s): Schiffer, C.A. , Shaqra, A.M. , Zvornicanin, S.N.
Date: 2025-04-14 Method: X-RAY DIFFRACTION Resolution: 2.19 Å Organism(s): Severe Acute Respiratory Syndrome Coronavirus 2 Sequences Data: 9O74_A , 9O74_B